申请人:Stieber Frank
公开号:US20100179149A1
公开(公告)日:2010-07-15
Compounds of the formula I, in which R
1
, R
2
, R
3
, R
4
, R
5
and X have the meanings indicated in claim
1
, are inhibitors of tyrosine kinases, in particular Met kinase, and can be employed, inter alia, for the treatment of tumours.
公式I中的化合物,其中R1、R2、R3、R4、R5和X的含义如权利要求1所示,是酪氨酸激酶的抑制剂,特别是Met激酶,并可用于治疗肿瘤等疾病。